Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $143.47M.
ENTERPRISE VALUE (EV)
$143.47M
CAMP4 Therapeutics Corporation
Market Cap
$251.01M
Enterprise Value (EV)
$143.47M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $251.01M | $143.47M |
| Invivyd, Inc. (IVVD)vs › | $251.06M | $99.38M |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $249.82M | $240.95M |
| InflaRx N.V. (IFRX)vs › | $248.92M | $82.54M |
| Galectin Therapeutics Inc. (GALT)vs › | $246.96M | $371.40M |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $260.11M | $228.90M |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $261.48M | $210.99M |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.19M | N/A |
| BioAge Labs Inc. (BIOA)vs › | $242.46M | $171.33M |
| Anika Therapeutics, Inc. (ANIK)vs › | $264.05M | $248.95M |
Market Cap
$251.01M
Total Debt
$1.97M
Cash
$109.52M
Enterprise Value
$143.47M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
